• Center on Health Equity & Access
  • Clinical
  • Health Care Cost
  • Health Care Delivery
  • Insurance
  • Policy
  • Technology
  • Value-Based Care

Segment 8 - Overall Survival and Ongoing Combination Clinical Trials

Article

While it would be nice to think that one and only one therapy would be effective at combatting cancer, combination therapy is needed, Kimberly Shafer-Weaver, PhD, said.

While it would be nice to think that one and only one therapy would be effective at combatting cancer, combination therapy is needed, Kimberly Shafer-Weaver, PhD, said.

While Jianda Yuan, MD, PhD, believes combination therapy is the future, he said clinical trials need to be designed carefully, and Dr Shafer-Weaver added that response rates are very patient specific.

“From a physician standpoint or from a payer standpoint, you need to think about, you know, are you going to spend these hundreds of thousands of dollars per patient that might not respond and then on top of it, you know, add another 1 or 2 biologics?” she said.

Related Videos
Wanmei Ou, PhD, vice president of product, data analytics, and AI at Ontada
Glenn Balasky, executive director of the Rocky Mountain Cancer Center.
Corey McEwen, PharmD, MS
dr linda bosserman
dr andrew leitner
Glenn Balasky during a video interview
dr joseph alvarnas
dr joseph alvarnas
Related Content
© 2024 MJH Life Sciences
AJMC®
All rights reserved.